(1)
Langley, R. G.; Crowley, J.; Gooderham, M.; Papp, K. A.; Korman, N. J.; Spelman, L.; Igarashi, A.; Ohtsuki, M.; Gupta, A. K.; Yamauchi, P.; Parno, J.; Mendelsohn, A. M.; Rozzo, S. J.; Eads, K. Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2. J of Skin 2020, 4, s39.